GTX30920
|
GeneTex International Corporation
|
Fluoroshield with DAPI
|
|
ICC/IF, IHC, IHC-Fr
|
|
GTX30921
|
GeneTex International Corporation
|
Fluoroshield with PI
|
|
ICC/IF, IHC
|
|
GTX30922
|
GeneTex International Corporation
|
ImmunoHistoMount
|
|
IHC
|
|
GTX30924
|
GeneTex International Corporation
|
Immuno In Situ Mount
|
|
IHC
|
|
GTX30926
|
GeneTex International Corporation
|
Fluoroshield with Phenylenediamine
|
|
ICC/IF, IHC
|
|
GTX30927
|
GeneTex International Corporation
|
Fluoroshield with DABCO
|
|
ICC/IF, IHC
|
|
GTX30967
|
GeneTex International Corporation
|
Endogenous peroxidase blocking kit
|
|
ICC/IF, IHC, IHC-P
|
|
HY-100001-10mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-100mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-5mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100001-50mg
|
MedChemexpress LLC
|
SKF-96365 (hydrochloride) [CAS 130495-35-1]
|
|
Cancer-Kinase/protease
|
|
HY-100003-10mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100003-5mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100003-50mg
|
MedChemexpress LLC
|
ML-210 [CAS 1360705-96-9]
|
|
Cancer-programmed cell death
|
|
HY-100005A-1mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
HY-100005A-10mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
HY-100005A-25mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
HY-100005A-5mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
HY-100005A-50mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
HY-100012-10mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-100mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-25mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-5mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100012-50mg
|
MedChemexpress LLC
|
CBR-5884 [CAS 681159-27-3]
|
|
Cancer-programmed cell death
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|